Jordan Stoll, MD

AAOS Now

Published 12/31/2019
|
Jordan Stoll, MD

In Favor of Innovation

Editor’s note: The following letter is in response to the article “Point/Counterpoint: Effective Implant Development,” which was written by Bruce H. Ziran, MD, FACS, and Douglas W. Lundy, MD, MBA, FACS, FAAOS, and published in the October 2019 issue of AAOS Now.

I read with interest the point/counterpoint debate concerning orthopaedic surgeons’ relationships with industry and product development. Both authors recognize the importance of surgeon input in the development of products to improve patient care. The issue becomes one of perceived or actual conflicts of interest. This concern should be easily mitigated.

I hold a patent for a surgical implant and have worked with an orthopaedic company in its development and use in an international market. I have been extremely impressed with the transparency and integrity of this company in all of our negotiations.

The contract can be constructed in a way to mitigate any conflicts of interest by eliminating any financial gain from the developing surgeon’s use of the product. Disclosures in published articles and at meetings also expose any potential conflicts of interest.

With these protections in place, I encourage orthopaedists to continue to innovate and explore methods and devices we use to improve the care we provide. I have found the process to be intellectually stimulating and rewarding and to the benefit of my patients.

Jordan Stoll, MD, is a U.S. Ski Team pool physician and works for Cornerstone Orthopaedics in Wheat Ridge, Colo. His disclosures are Stryker Corp., and Innomed, Inc.